Sharda Cropchem Limited has informed the Exchange regarding a press release dated July 25, 2025, titled "Press Release".
SHARDACROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sharda Cropchem reported strong Q1 FY26 results with consolidated revenue rising 25% year-on-year to Rs. 984.8 crore, driven by about 13% volume growth and improved pricing. Gross profit jumped 53% to Rs. 349.2 crore, with gross margin expanding 630 basis points to 35.5% on stabilising input costs. EBITDA grew 67% to Rs. 142.2 crore (margin at 14.4%, up 350 bps), while profit after tax surged 424% to Rs. 142.8 crore versus Rs. 27.3 crore in Q1 FY25. Europe led growth at 43% YoY (Rs. 523 crore), herbicides and insecticides both grew over 30%, and the company remains debt-free with Rs. 791 crore in cash and liquid investments. Management guided for about 15% topline growth in FY26 with EBITDA margins in the 15–18% range and planned capex of Rs. 400–450 crore.
Strong beat on margins and profitability, debt-free balance sheet with healthy cash, and a confident FY26 growth outlook are positive signals for shareholders. The stock may see a positive reaction given the sharp jump in PAT and forward guidance.